Aberdeen Group
ABBV icon

Aberdeen Group’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$430M Buy
2,322,737
+71,966
+3% +$13.3M 0.73% 16
2025
Q1
$466M Buy
2,250,771
+488,940
+28% +$101M 0.91% 16
2024
Q4
$311M Sell
1,761,831
-224,833
-11% -$39.6M 0.58% 26
2024
Q3
$389M Sell
1,986,664
-63,210
-3% -$12.4M 0.71% 21
2024
Q2
$352M Sell
2,049,874
-204,819
-9% -$35.1M 0.67% 19
2024
Q1
$411M Sell
2,254,693
-19,109
-0.8% -$3.48M 0.81% 16
2023
Q4
$352M Buy
2,273,802
+830,187
+58% +$129M 0.76% 17
2023
Q3
$215M Sell
1,443,615
-137,483
-9% -$20.5M 0.55% 40
2023
Q2
$213M Sell
1,581,098
-1,154,778
-42% -$156M 0.5% 45
2023
Q1
$436M Sell
2,735,876
-101,306
-4% -$16.1M 1.09% 11
2022
Q4
$459M Sell
2,837,182
-30,313
-1% -$4.9M 1.25% 9
2022
Q3
$385M Sell
2,867,495
-160,380
-5% -$21.5M 1.15% 9
2022
Q2
$463M Sell
3,027,875
-581,525
-16% -$89M 1.46% 8
2022
Q1
$594M Sell
3,609,400
-1,245,427
-26% -$205M 1.52% 7
2021
Q4
$657M Buy
4,854,827
+177,490
+4% +$24M 1.44% 5
2021
Q3
$512M Sell
4,677,337
-34,805
-0.7% -$3.81M 1.15% 9
2021
Q2
$531M Buy
4,712,142
+144,264
+3% +$16.2M 1.16% 10
2021
Q1
$494M Buy
4,567,878
+256,073
+6% +$27.7M 1.12% 12
2020
Q4
$462M Buy
4,311,805
+185,649
+4% +$19.9M 1.13% 11
2020
Q3
$361M Sell
4,126,156
-164,310
-4% -$14.4M 0.96% 15
2020
Q2
$421M Buy
4,290,466
+357,374
+9% +$35.1M 1.14% 9
2020
Q1
$300M Buy
3,933,092
+1,693,650
+76% +$129M 0.95% 22
2019
Q4
$198M Buy
2,239,442
+53,407
+2% +$4.73M 0.48% 57
2019
Q3
$166M Buy
2,186,035
+1,225,068
+127% +$92.8M 0.41% 69
2019
Q2
$69.9M Buy
960,967
+67,080
+8% +$4.88M 0.16% 119
2019
Q1
$72M Buy
893,887
+120,383
+16% +$9.7M 0.16% 119
2018
Q4
$69.5M Sell
773,504
-50,442
-6% -$4.54M 0.17% 120
2018
Q3
$77.9M Sell
823,946
-221,533
-21% -$21M 0.15% 139
2018
Q2
$96.9M Sell
1,045,479
-1,731,287
-62% -$160M 0.19% 116
2018
Q1
$263M Buy
2,776,766
+83,073
+3% +$7.86M 0.52% 52
2017
Q4
$261M Buy
2,693,693
+696,254
+35% +$67.4M 0.5% 53
2017
Q3
$177M Buy
+1,997,439
New +$177M 0.32% 79